Have you been diagnosed with bipolar disorder? Are you suffering from symptoms such as racing thoughts, a lack of focus, high energy or irritability? You may be eligible to participate in a research study at Sharp Mesa Vista Hospital. Participants must be:
- Over age 18
- Diagnosed with bipolar disorder
- Bipolar Disorder With a Depressive Episode
This randomized, double-blind, placebo-controlled, phase 3 study will evaluate the efficacy and safety of once-a-day, TAK-375 (Ramelteon) tablet for sublingual administration (TAK-375SL tablet) as an adjunctive therapy in the treatment of acute depressive episodes associated with bipolar 1 disorder. Participants will attend 10 clinic visits over 8 weeks. Many participants continue with their current medication for bipolar disorder throughout the study. This study is appropriate for individuals age 18 to 75 who have been diagnosed with bipolar 1 disorder and have experienced a recent depressive episode. Learn more about this study.
How to Enroll
To learn more or to enroll in a clinical trial, call 858-836-8350 or send us an email.
For More Information
For more information about other research studies at Sharp Mesa Vista Hospital, please visit Sharp Mesa Vista Clinical Research Center.
Please note that Sharp HealthCare does not control or endorse the information presented on external websites, nor do these websites endorse the information found on www.sharp.com.